{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:08:15Z","timestamp":1770822495623,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.ajog.2004.10.605","type":"journal-article","created":{"date-parts":[[2005,2,26]],"date-time":"2005-02-26T19:43:45Z","timestamp":1109447025000},"page":"813-818","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":119,"title":["Racial differences in the overexpression of epidermal growth factor type II receptor (HER2\/neu): A major prognostic indicator in uterine serous papillary cancer"],"prefix":"10.1016","volume":"192","author":[{"given":"Alessandro D.","family":"Santin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Bellone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric R.","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michela","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin J.","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen H.","family":"Kay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan J.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Pecorelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2004.10.605_bib1","first-page":"5","article-title":"Cancer statistic: 2003","volume":"53","author":"Jemal","year":"2003","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajog.2004.10.605_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma","volume":"15","author":"Bohkman","year":"1983","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2004.10.605_bib3","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/jnci\/60.6.1209","article-title":"Contrasts in survival of black and white cancer patients, 1960-73","volume":"60","author":"Axtell","year":"1978","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2004.10.605_bib4","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0002-9378(87)80089-3","article-title":"Racial differences in survival of women with endometrial cancer","volume":"157","author":"Bain","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.10.605_bib5","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/0002-9378(95)90261-9","article-title":"Endometrial cancer: stage at diagnosis and associated factors in black and white patients","volume":"173","author":"Barrett","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.10.605_bib6","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/1097-0142(19920501)69:9<2349::AID-CNCR2820690925>3.0.CO;2-7","article-title":"A collaborative study of differences in the survival rates of black patients and white patients with cancer","volume":"69","author":"Howard","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.ajog.2004.10.605_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ssu.2980100107","article-title":"FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87: SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina","volume":"10","author":"Kosary","year":"1994","journal-title":"Semin Surg Oncol"},{"key":"10.1016\/j.ajog.2004.10.605_bib8","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12<2629::AID-CNCR30>3.0.CO;2-2","article-title":"The National Cancer Data Base report on endometrial carcinoma in African-American women","volume":"83","author":"Hicks","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.ajog.2004.10.605_bib9","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/jama.1994.03520120057031","article-title":"Racial differences in survival from breast cancer: results of the National Cancer Institute Black\/White Cancer Survival Study","volume":"272","author":"Eley","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2004.10.605_bib10","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/00003081-199609000-00016","article-title":"Endometrial papillary serous carcinoma: patterns of spread and treatment","volume":"39","author":"Nicklin","year":"1996","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.10.605_bib11","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1006\/gyno.1994.1208","article-title":"Uterine papillary serous carcinoma: patterns of metastatic spread","volume":"54","author":"Goff","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2004.10.605_bib12","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ygyno.2003.08.018","article-title":"Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases","volume":"91","author":"Slomovitz","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2004.10.605_bib13","first-page":"1271","article-title":"Overexpression of HER-2\/neu in uterine serous papillary cancer","volume":"8","author":"Santin","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajog.2004.10.605_bib14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0002-9378(91)90615-X","article-title":"Overexpression of HER-2\/neu in endometrial cancer is associated with advanced stage disease","volume":"164","author":"Berchuck","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.10.605_bib15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0090-8258(92)90103-P","article-title":"HER-2\/neu expression: a major prognostic factor in endometrial cancer","volume":"47","author":"Hetzel","year":"1992","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2004.10.605_bib16","first-page":"2087","article-title":"Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer","volume":"49","author":"Wright","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajog.2004.10.605_bib17","first-page":"4087","article-title":"Overexpression of HER-2\/neu is associated with poor survival in advanced epithelial ovarian cancer","volume":"50","author":"Berchuck","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajog.2004.10.605_bib18","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/j.1460-2075.1996.tb00356.x","article-title":"ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer","volume":"15","author":"Karunagaran","year":"1996","journal-title":"EMBO J"},{"key":"10.1016\/j.ajog.2004.10.605_bib19","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/emboj\/16.7.1647","article-title":"ErbB-2, the preferred heterodimerization partner of all erbB receptors is a mediator of lateral signaling","volume":"16","author":"Graus-Porta","year":"1997","journal-title":"EMBO J"},{"key":"10.1016\/j.ajog.2004.10.605_bib20","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/0029-7844(95)00238-M","article-title":"Relationship between race and interval to treatment in endometrial cancer","volume":"86","author":"Liu","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.10.605_bib21","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S0002-9378(96)70036-4","article-title":"p53 overexpression in advanced-stage endometrial adenocarcinoma","volume":"175","author":"Kohler","year":"1996","journal-title":"Am J Obstet Gynecol"},{"issue":"suppl","key":"10.1016\/j.ajog.2004.10.605_bib22","doi-asserted-by":"crossref","first-page":"S229","DOI":"10.1016\/S0002-9378(97)70380-6","article-title":"Racial disparity in overexpression of the p53 tumor suppressor gene in stage I endometrial cancer","volume":"176","author":"Clifford","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.10.605_bib23","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","article-title":"Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2","volume":"344","author":"Slamon","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2004.10.605_bib24","first-page":"465","article-title":"Her2\/neu expression in uterine papillary serous cancers [abstract]","volume":"22","author":"Villella","year":"2003","journal-title":"Proc Am Soc Clin Oncol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937804018095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937804018095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:59:05Z","timestamp":1757584745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937804018095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0002937804018095"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2004.10.605","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Racial differences in the overexpression of epidermal growth factor type II receptor (HER2\/neu): A major prognostic indicator in uterine serous papillary cancer","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2004.10.605","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}